Breathe Well Live Well
|
Abbott, SkyePharma Part Ways on Asthma Drug Flutiform
BioWorld Online It was no surprise that the two firms parted ways on the asthma drug candidate after the FDA in January said further clinical trials were needed to file for … |
View full post on asthma – Google News
|
Kos Pharmaceuticals and SkyePharma terminate license agreement for flutiform
Trading Markets (press release) Flutiform is used for adult and adolescent asthma. Under the terms of the agreement, Kos has the right to perform further clinical development for … Abbott, Skyepharma Part Ways On Asthma Drug Flutiform |
View full post on asthma – Google News
|
Abbott, Skyepharma Part Ways On Asthma Drug Flutiform
PharmaLive (press release) (subscription) It was no surprise that the two firms parted ways on the asthma drug candidate after the FDA in January said further clinical trials were needed to file for … |
View full post on asthma – Google News
 Genetic Engineering News |
SkyePharma falls as Abbott gets shot of asthma drug
This is London Drugmaker SkyePharma today saw its shares plunge 5% after pharmaceuticals giant Abbott Laboratories ended the deal to sell its asthma drug Flutiform in … SkyePharma loses US partner Abbott bows out of Flutiform pact Abbott Returns US Flutiform Rights to SkyePharma after Negative FDA Feedback |
View full post on asthma – Google News
 Stockopedia |
Skyepharma slides as US group ends asthma drug deal
The Guardian Shares in Skyepharma have fallen around 5% after another setback for its asthma treatment flutiform. The company has announced that Abbott Laboratories has … SkyePharma loses US partner Abbot shelves interest in SkyePharma's Flutiform SkyePharma says Abbott ends US Flutiform deal |
View full post on asthma – Google News